VRAX
Virax Biolabs Group Limited
NASDAQ · Healthcare · Biotechnology · GB
$2.63
+2.54%Next report
Analyst consensus
- Next report date
- Dec 2, 2026
- EPS estimate
- -$1.75
- Revenue estimate
- $12.4K
Latest reported
- Last report date
- Dec 2, 2025
- EPS actual
- -$0.49
- EPS estimate
- —
- Revenue actual
- $1.6K
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 2, 2026